期刊文献+

血缘关系供者外周血干细胞移植中移植物细胞组分对造血重建和移植物抗宿主病的影响 被引量:3

Effects of graft compositions on hematopoietic reconstitution and graft-versus-host disease in related donor peripheral blood stem cell transplantation
原文传递
导出
摘要 目的探讨HLA全相合血缘关系供者外周血干细胞移植(PBSCT)中移植物细胞组分对恶性血液病患者移植后造血重建、移植物抗宿主病(GVHD)的影响。方法回顾性分析我科107例接受HLA全相合血缘关系供者PBSCT的恶性血液病患者,其移植物细胞组分与移植后患者造血重建、GVHD的关系。结果移植物各细胞组分与粒细胞重建时间无关;单个核细胞(MNC)、CD34^+细胞数与血小板重建时间呈负相关(r值分别为-0.32和-0.21,P值均〈0.05)。CD34^+、CD34^+CD38^-细胞数与急性GVHD发生呈负相关(r分别为-0.24和-0.29,P值均〈0.05)。淋巴细胞各亚群数量与急性GVHD发生均无明显关系。CD25^+CD4^+、CD3^+、CD4^+CD3^+细胞数及CD4^+/CD8^+细胞比值与慢性GVHD发生均呈正相关(P值均〈0.05),且相关系数均大于0.4,其中CD25^+CD4^+细胞数与慢性GVHD相关系数高达0.78。CD34^+、CD34^+CD38^-细胞数与慢性GVHD发生无明显关系。结论PBSCT中输入MNC、CD34^+、CD34^+CD38^-细胞数增加到一定阈值后,增加细胞数并不能进一步有效促进患者造血重建,反而有可能因输入淋巴细胞数增加而增加患者慢性GVHD、广泛慢性GVHD的发生率。 Objective To explore the effects of graft composition on hematopoietic reconstitution and graft-versus-host disease(GVHD) in HLA-identical related donor peripheral blood stem cell transplantation (PBSCT) for hematological malignancies. Methods The relationship between the number of graft composition and their hematopoietic reconstitution and GVHD in 107 patients with hematological malignancies undergoing HLA-identical related donor PBSCT was retrospectively analyzed. Results None of the graft composition numbers had correlation with the time of neutrophil reconstitution. There was a negative correlation between the number of mononuclear cells (MNCs) or CD34^+ cells and the time of platelet reconstitution (P 〈 0.05 ) with the absolute correlation coefficients below 0.4, and so did between the number of CD34^+ or CD34^+ CD38^- cells and the development of acute GVHD ( P 〈 0.05 ) and their absolute correlation coefficients. Each lymphocyte subset number had no correlation with acute GVHD. There was a positive correlation between the number of CD25^+ CD4^+ , CD3^+ or CD4^+ CD3^+ cells or CD4^+/CD8^+ ratio and the development of chronic GVHD ( P 〈 0.05 ). And the correlation coefficients all exceeded 0.4, more over, CD25^+ CD4^+ cells number reached up to 0.78. CD34^+ , CD34^+ CD38^- cells number had no correlation with chronic GVHD. Conclusion In HLA-identical related donor PBSCT, further increasing infused MNC, CD34^+, CD34^+ CD38^- cells can no more accelerated hematopoietic reconstitution after these cells attained their threshold values, otherwise the incidence of cGVHD might increase clue to the increase of the accompanied lymphoeytes.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第5期333-336,共4页 Chinese Journal of Hematology
关键词 造血干细胞移植 造血重建 移植物抗宿主病 Hematopoietic stem cell transplantation Hematopoietic reconstitution Graft-versushost disease
  • 相关文献

参考文献9

  • 1Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with hone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol,2005, 23:5074-5087.
  • 2Przepiorka D. Grading and management of graft-vs-host disease// Laughlin M J, Lazarus HM. Allogeneic stem cell transplantation. Totowa : Humana Press Inc,2003:237-260.
  • 3李佩,张国芸,朱苹,吴蓓倩,牛强,谢毅.低剂量rhG-CSF对56例非血缘供者外周造血干细胞动员[J].中国实验血液学杂志,2007,15(2):348-351. 被引量:12
  • 4Kroger N, Renges H, Sonnenberg S, et al. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant, 2002, 29: 727-730.
  • 5Mohty M,Bilger K,Jourdan E,et al. Higher doses of CD34 + peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia,2003,17:869-875.
  • 6Cottler-Fox MH, Lapidot T, Petit I, et al. Stem cell mobilization. Hematology Am Soc Hematol Educ Program ,2003:419-437.
  • 7Cao TM, Wong RM, Sheehan K, et al. CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. Exp Hematol,2005 ,33 :279-285.
  • 8Stanzani M,Martins SL,Saliba RM,et al. CD25 expression on donor CD4 + or CD8 + T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood ,2004,103 : 1140-1146.
  • 9Clark F J, Gregg R, Piper K,et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 + CD25 high regulatory T cells. Blood ,2004,103:2410-2416.

二级参考文献9

  • 1Bakken R,van-Walreaven AM,Egeland T,et al.Donor commitment and patient needs.Bone Marrow Transplant,2004;33:225 -230
  • 2Suzuya H,Watanabe T,Nakagawa R,et al.Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.Vox Sang,2005; 89:229 -235
  • 3Anderlini P,Donato M,Chan KW,et al.Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:the M.D.Anderson Cancer Center experience.Transfution,1999;39:555-560
  • 4Bensinger W,Buckner CD,Rowley S,et al.Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.Bone Marrow Transplant,1996;17(Suppl 2):S19 -S21
  • 5Grigg AP.Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia.Blood,2001 ;97:3998-399
  • 6Stroncek D,Shawker T,Follmann D,et al.G-CSF induced spleen size changes in peripheral blood progenitor cell donors.Transfusion,2003 ;43:609 -613
  • 7Bonsignore MR,Morici G,Santoro A,et al.Circulating hematopoietic progenitor cells in runners.J Appl Physiol,2002;93:1691 -1697
  • 8Croop JM,Cooper R,Seshadri R,et al.Large-seale mobilization and isolation of CD34+ cells from normal donor.Bone Marrow Transplant,2000; 26:1271-1279
  • 9陈彤,谢毅.VLA-4整联蛋白和造血细胞迁移之间的相关关系研究(英文)[J].中国实验血液学杂志,2003,11(3):230-234. 被引量:1

共引文献11

同被引文献36

  • 1Lane TA,Ho AD,Bashey A,et al.Mobilization of bloodderived stem and progenitor cells in normal subjects by granulocyte-macrophage-and granulocyte colony-stimulating factors.Transplantation,1999,39(1):39-47.
  • 2Ho AD,Young D,Maruyama M,et al.Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF,GM-CSF vs a combination of both.Exp Hematol,1996,24(13):1460-1468.
  • 3Lane TA,Law P,Maruyama M,et al.Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF:potential role in allogeneic marrow transplantation.Blood,1995,85 (1):275-282.
  • 4Kamel AM,El-Sharkawy N,Mahmoud HK,et al.Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation.Bone Marrow Transplant,2005,35(2):129-136.
  • 5Pratt G,Rawstron AC,English AE,et al.Analysis of CD34+cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose,but steady state levels do not correlate with bone marrow reserve.Br J Haematol,2001,114(4):937-943.
  • 6Dazzi C,Cariello A,Rosti G,et al.Relationships between total CD34+ cells reinfused,CD34+ subsets and engraftment kinetics in breast cancer patients.Hematologica,2000,85(4):396-402.
  • 7Baech J,Johnsen HE.Concise review:technical aspects and clinical impact of hematopoietic progenitor subset quantification.Stem Cells,2000,18(2):76-86.
  • 8Pastore D,Mestice A,Perrone T,et al.Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.Bone Marrow Transplant,2008,41 (11):977-981.
  • 9Devine SM,Brown RA,Mathews V,et al.Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.Bone Marrow Transplant,2005,36(6):531-538.
  • 10Vij R,Brown RA,Adkin D,et al.Mobilization of normal donors with G-CSF and GM-CSF is associated with improved yield of progenitors and increased numbers of activated dendritic cells.Blood,1998,90:682.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部